| 臺大學術典藏 |
2021-04-29T00:48:10Z |
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature
|
Frezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S. |
| 臺大學術典藏 |
2021-09-04T05:16:21Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-14T23:18:41Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
TUNG-HUNG SU; Hsu, Shih Jer; JIA-HORNG KAO |
| 國立臺灣大學 |
2008-04 |
Systemic therapy for metastatic urothelial carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Pu, Yeong-Shiau; Vogelzang, Nicholas J. |
| 國立臺灣大學 |
2008 |
Systemic Therapy for Metastatic Urothelial Carcinoma
|
林家齊; 徐志宏; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H; Pu Y.-S; Vogelzang N.J. |
| 臺大學術典藏 |
2021-02-02T00:46:53Z |
Systemic therapy for metastatic urothelial carcinoma
|
Lin C.-C.; Hsu C.-H.; YEONG-SHIAU PU; Vogelzang N.J. |
| 臺大學術典藏 |
2022-09-15T01:09:52Z |
Systemic therapy for metastatic urothelial carcinoma
|
Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.; Vogelzang N.J. |
| 國家衛生研究院 |
2022-09 |
Systemic treatment of advanced unresectable hepatocellular carcinoma after first-line therapy: Expert recommendations from Hong Kong, Singapore, and Taiwan
|
Yau, T;Tai, D;Chan, SL;Huang, YH;Choo, SP;Hsu, C;Cheung, TT;Lin, SM;Yong, WP;Lee, J;Leung, T;Shum, T;Yeung, CSY;Tai, AY;Law, ALY;Cheng, AL;Chen, LT |
| 臺大學術典藏 |
2021-03-10T02:36:32Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.;Jan I.-S.;Chang D.-Y.;Lin C.-H.;Chen I.-C.;Chen H.-M.;Cheng A.-L.;Yen-Shen Lu; Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; YEN-SHEN LU |
